ACT-ED: Accessibility and Feasibility of an Acceptance and Commitment Therapy (ACT)-Based Eating Disorder Prevention Program
ACT-ED: ACT-Based Eating Disorder Prevention Program
1 other identifier
interventional
5
1 country
1
Brief Summary
The goal of this clinical trial is to investigate the accessibility and feasibility of an online group prevention program developed for women at risk for eating disorders. Also, to conduct a preliminary analysis of treatment efficacy. The main questions it aims to answer are: Does ACT-ED an acceptable intervention for women at risk for eating disorders? Does intervention result in reduced eating pathology? Participants will: Join the online, 4-session ACT-based group program Fill the measures at Pre-test, post-test and follow-up assessment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 18, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
February 2, 2025
CompletedFirst Submitted
Initial submission to the registry
April 11, 2025
CompletedFirst Posted
Study publicly available on registry
April 25, 2025
CompletedJune 10, 2025
April 1, 2025
3 months
April 11, 2025
June 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Disordered eating, assessed by the Turkish form of the Eating disorder examination questionnaire (EDE-Q)
Disordered eating is a risk factor for eating disorders. In a prevalence study conducted in Türkiye, individuals with EDE-Q scores of 3.03 and above were defined as a high-risk group (Deveci, 2020). In this study, EDE-Q scores were assessed for inclusion criteria during enrollment. Additionally, changes in EDE-Q scores are assessed at post-test and follow-up to assess treatment effect.
Baseline (pretest), week 4(posttest), 1-month follow-up
Secondary Outcomes (7)
Body dissatisfaction, assessed by the Turkish form of Body shape Questionnaire (BSQ)
Baseline (pretest), week 4(posttest), 1-month follow-up
Body image flexibility, assessed by the Turkish form of the Body Image Acceptance and Action Questionnaire (BI-AAQ)
Baseline (pretest), week 4(posttest), 1-month follow-up
Psychological flexibility, assessed by Acceptance and Action Questionnaire (AAQ-II)
Baseline (pretest), week 4(posttest), 1-month follow-up
Present moment awareness, assessed by the Turkish form of the Freiburg Mindfulness Inventory (FMI)
Baseline (pretest), week 4(posttest), 1-month follow-up
Contextual Self, assessed by the Turkish form of the Self-As-Context Scale (SACS)
Baseline (pretest), week 4(posttest), 1-month follow-up
- +2 more secondary outcomes
Study Arms (1)
Group intervention
EXPERIMENTALACT-based online group intervention. 4 sessions of 1.5 hours, held once a week
Interventions
This intervention protocol was developed specifically for women who have body dissatisfaction and disordered eating behaviors. Based on the psychological flexibility model (hexaflex), it is designed to improve people's body image flexibility using Acceptance and Commitment Therapy techniques. Interventions related to the dimensions of the hexaflex were made during each session. The first session covers values and goal setting. The second session includes creative hopelessness, acceptance, and self-compassion. The third session covers defusion and mindfulness. The last session focuses on self-as-context exercises and the combined use of skills for committed action.
Eligibility Criteria
You may qualify if:
- Being a woman aged 18 years or older
- Exhibiting disordered eating behaviors (EDE-Q score ≥ 3.03)
- Experiencing body dissatisfaction (BSQ-34 score ≥ 110)
You may not qualify if:
- Current or past diagnosis/treatment for an eating disorder
- Currently receiving psychotherapy
- Currently receiving psychiatric medication (not excluded if there has been no change in treatment in the last 6 months)
- Having chronic psychiatric disorders (e.g. psychosis)
- Having a substance addiction
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ibn Haldun University Psychotherapy Application and Research Center (IPAM)
Istanbul, Basaksehir, 34480, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Emine Serra Nebati
Ibn Haldun University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
April 11, 2025
First Posted
April 25, 2025
Study Start
November 18, 2024
Primary Completion
February 2, 2025
Study Completion
February 2, 2025
Last Updated
June 10, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared due to confidentiality concerns and ethical considerations.